Silva C

Instituto Dante Pazzanese de Cardiologia

2
Publications in this database

PubMed name variants: Silva C. Uses the same surname-and-first-initial grouping as the researcher table; matches are not verified identities.

4
Career-wide h-index · OpenAlex
(62 citations, 15 total works)

Career-wide Research Topics · OpenAlex

Topic counts cover the OpenAlex author’s full publication record, across all conditions.

Anesthesia and Sedative Agents (7)Cardiac and Coronary Surgery Techniques (5)Biomedical and Chemical Research (3)Airway Management and Intubation Techniques (2)Hemodynamic Monitoring and Therapy (2)

Erythromelalgia Publications

Combination gel of 2% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain - a case report of pain control success.

Portugal F, Araújo A, Silva C, Campos M, Valentim A
Revista espanola de anestesiologia y reanimacion •

Erythromelalgia (EM) is a rare autosomal dominant neuropathy characterized by the combination of severe burning pain and erythematous warm extremities. Chronic pain control is most often unsuccessful and a completely effective therapy is yet to be identified. Recent studies have reported significant improvements in pain management using a combination of amitriptyline and ketamine in a topical formulation. We describe a 1-year follow-up pain control success case of a male patient with EM, proposed for topical use of a 2% Amitriptyline and 0.5% Ketamine gel.

Combination gel of 2% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain - a case report of pain control success.

Portugal F, Araújo A, Silva C, Campos M, Valentim A
Revista espanola de anestesiologia y reanimacion •

Erythromelalgia (EM) is a rare autosomal dominant neuropathy characterized by the combination of severe burning pain and erythematous warm extremities. Chronic pain control is most often unsuccessful and a completely effective therapy is yet to be identified. Recent studies have reported significant improvements in pain management using a combination of amitriptyline and ketamine in a topical formulation. We describe a 1-year follow-up pain control success case of a male patient with EM, proposed for topical use of a 2% Amitriptyline and 0.5% Ketamine gel.